Literature DB >> 9169738

Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.

I S Eriks1, C L Emerson.   

Abstract

Members of the Mycobacterium avium complex are a family of bacteria that persist within macrophages in the face of an immune response. Elimination of these organisms is likely due to cytokine-induced macrophage activation. Because macrophage activation by tumor necrosis factor alpha (TNF-alpha) appears critical for killing of intracellular M. avium, early downregulation of TNF-alpha levels in infected macrophages has been suggested as a survival mechanism for virulent strains of M. avium. We examined the relationship between TNF-alpha and growth of M. avium strains of differing virulence, as measured by their ability to grow in murine bone marrow-derived macrophages. When exogenous TNF-alpha was added immediately following macrophage infection, significant growth inhibition of virulent M. avium strains was observed. If TNF-alpha addition was delayed by 24 h or more, growth inhibition was abrogated. To determine if early downregulation of TNF-alpha levels could explain the differential growth of virulent and avirulent strains, levels of TNF-alpha and prostaglandin E2 (PGE2), which has been shown to suppress TNF-alpha production in uninfected macrophages, were quantified over time. Upregulation of both TNF-alpha and PGE2, as measured by enzyme-linked immunosorbent assay, was evident by 6 h postinfection, indicating that the ability of M. avium to replicate in macrophages was not directly correlated with early downregulation of TNF-alpha production. However, TNF-alpha bioactivity, as measured by cytotoxicity, was significantly decreased in virulent M. avium strains at all time periods examined. Treatment of infected macrophages with gamma interferon immediately after infection resulted in significantly increased levels of nitric oxide but did not affect the growth of virulent M. avium strains. These results suggest that while significant levels of TNF-alpha are present in supernatants from all M. avium strains, levels of biologically active TNF-alpha are significantly reduced in supernatants from virulent M. avium strains. Preliminary results suggest that upregulation of the soluble p75 TNF receptor may be one mechanism by which TNF-alpha bioactivity reduction occurs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169738      PMCID: PMC175290          DOI: 10.1128/iai.65.6.2100-2106.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.

Authors:  J Wu; F Q Cunha; F Y Liew; W Y Weiser
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

2.  The cellular immunology of bovine paratuberculosis: immunity may be regulated by CD4+ helper and CD8+ immunoregulatory T lymphocytes which down-regulate gamma/delta+ T-cell cytotoxicity.

Authors:  R J Chiodini; W C Davis
Journal:  Microb Pathog       Date:  1993-05       Impact factor: 3.738

3.  Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates.

Authors:  A Y Tsang; J C Denner; P J Brennan; J K McClatchy
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

4.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

5.  Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.

Authors:  S K Furney; P S Skinner; A D Roberts; R Appelberg; I M Orme
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors.

Authors:  D R Branch; A Shah; L J Guilbert
Journal:  J Immunol Methods       Date:  1991-10-25       Impact factor: 2.303

7.  Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor.

Authors:  I M Orme; S K Furney; P S Skinner; A D Roberts; P J Brennan; D G Russell; H Shiratsuchi; J J Ellner; W Y Weiser
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.

Authors:  R Appelberg; I M Orme
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

9.  Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis.

Authors:  J S Friedland; R J Shattock; J D Johnson; D G Remick; R E Holliman; G E Griffin
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

10.  The cellular immunology of bovine paratuberculosis: the predominant response is mediated by cytotoxic gamma/delta T lymphocytes which prevent CD4+ activity.

Authors:  R J Chiodini; W C Davis
Journal:  Microb Pathog       Date:  1992-12       Impact factor: 3.738

View more
  10 in total

1.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

2.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.

Authors:  A Corti; L Fattorini; O F Thoresen; M L Ricci; A Gallizia; M Pelagi; Y Li; G Orefici
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Inhibition of tumor necrosis factor alpha alters resistance to Mycobacterium avium complex infection in mice.

Authors:  S Bala; K L Hastings; K Kazempour; S Inglis; W L Dempsey
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Characterization of lung inflammation and its impact on macrophage function in aging.

Authors:  Cynthia H Canan; Nandan S Gokhale; Bridget Carruthers; William P Lafuse; Larry S Schlesinger; Jordi B Torrelles; Joanne Turner
Journal:  J Leukoc Biol       Date:  2014-06-16       Impact factor: 4.962

6.  Differential responses of bovine macrophages to Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium.

Authors:  Douglas J Weiss; Oral A Evanson; Andreas Moritz; Ming Qi Deng; Mitchell S Abrahamsen
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection.

Authors:  Nasiema Allie; Sergei I Grivennikov; Roanne Keeton; Nai-Jen Hsu; Marie-Laure Bourigault; Nathalie Court; Cecile Fremond; Vladimir Yeremeev; Yuriy Shebzukhov; Bernhard Ryffel; Sergei A Nedospasov; Valerie F J Quesniaux; Muazzam Jacobs
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation.

Authors:  Ivy M Dambuza; Roanne Keeton; Nai-Jen Hsu; Nasiema Allie; Valérie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

9.  Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains.

Authors:  Harish K Janagama; Kwang il Jeong; Vivek Kapur; Paul Coussens; Srinand Sreevatsan
Journal:  BMC Microbiol       Date:  2006-02-14       Impact factor: 3.605

Review 10.  Nontuberculous mycobacterial osteomyelitis.

Authors:  Sheng Bi; Fei-Shu Hu; Hai-Ying Yu; Kai-Jin Xu; Bei-Wen Zheng; Zhong-Kang Ji; Jun-Jie Li; Mei Deng; Hai-Yang Hu; Ji-Fang Sheng
Journal:  Infect Dis (Lond)       Date:  2015-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.